ID   U2QL1_HUMAN             Reviewed;         161 AA.
AC   A1L167;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   10-MAY-2017, entry version 89.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2Q-like protein 1;
DE            EC=2.3.2.23;
DE   AltName: Full=E2Q-like ubiquitin-conjugating enzyme 1;
GN   Name=UBE2QL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, CHROMOSOMAL TRANSLOCATION, INTERACTION
RP   WITH FBXW7, INVOLVEMENT IN RCC, MUTAGENESIS OF CYS-88, AND ACTIVE
RP   SITE.
RX   PubMed=24000165; DOI=10.1002/humu.22433;
RA   Wake N.C., Ricketts C.J., Morris M.R., Prigmore E., Gribble S.M.,
RA   Skytte A.B., Brown M., Clarke N., Banks R.E., Hodgson S.,
RA   Turnell A.S., Maher E.R., Woodward E.R.;
RT   "UBE2QL1 is disrupted by a constitutional translocation associated
RT   with renal tumor predisposition and is a novel candidate renal tumor
RT   suppressor gene.";
RL   Hum. Mutat. 34:1650-1661(2013).
CC   -!- FUNCTION: Probable E2 ubiquitin-protein ligase that catalyzes the
CC       covalent attachment of ubiquitin to target proteins. May
CC       facilitate the monoubiquitination and degradation of MTOR and
CC       CCNE1 through interaction with FBXW7.
CC       {ECO:0000269|PubMed:24000165}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with FBXW7. {ECO:0000269|PubMed:24000165}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24000165}.
CC   -!- DISEASE: Note=A chromosomal aberration involving UBE2QL1 has been
CC       found in a sporadic case of renal cell carcinoma (RCC).
CC       Translocation t(5;19)(p15.3;q12). No gene is disrupted by the
CC       chromosome 19 breakpoint. {ECO:0000269|PubMed:24000165}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI27724.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAI50555.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC127723; AAI27724.1; ALT_INIT; mRNA.
DR   EMBL; BC150554; AAI50555.1; ALT_INIT; mRNA.
DR   CCDS; CCDS47189.1; -.
DR   RefSeq; NP_001138633.1; NM_001145161.2.
DR   UniGene; Hs.126856; -.
DR   UniGene; Hs.731466; -.
DR   ProteinModelPortal; A1L167; -.
DR   SMR; A1L167; -.
DR   BioGrid; 126384; 1.
DR   STRING; 9606.ENSP00000382713; -.
DR   iPTMnet; A1L167; -.
DR   PhosphoSitePlus; A1L167; -.
DR   BioMuta; UBE2QL1; -.
DR   PaxDb; A1L167; -.
DR   PRIDE; A1L167; -.
DR   Ensembl; ENST00000399816; ENSP00000382713; ENSG00000215218.
DR   GeneID; 134111; -.
DR   KEGG; hsa:134111; -.
DR   UCSC; uc003jdp.5; human.
DR   CTD; 134111; -.
DR   DisGeNET; 134111; -.
DR   GeneCards; UBE2QL1; -.
DR   HGNC; HGNC:37269; UBE2QL1.
DR   HPA; HPA057414; -.
DR   MIM; 615832; gene.
DR   neXtProt; NX_A1L167; -.
DR   OpenTargets; ENSG00000215218; -.
DR   PharmGKB; PA165660602; -.
DR   eggNOG; KOG0897; Eukaryota.
DR   eggNOG; ENOG410XRET; LUCA.
DR   GeneTree; ENSGT00390000018573; -.
DR   HOGENOM; HOG000007757; -.
DR   HOVERGEN; HBG061368; -.
DR   InParanoid; A1L167; -.
DR   KO; K10582; -.
DR   OMA; PKGWSSA; -.
DR   OrthoDB; EOG091G0LGG; -.
DR   PhylomeDB; A1L167; -.
DR   TreeFam; TF313338; -.
DR   SignaLink; A1L167; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2QL1; human.
DR   GenomeRNAi; 134111; -.
DR   PRO; PR:A1L167; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000215218; -.
DR   Genevisible; A1L167; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:MGI.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chromosomal rearrangement; Complete proteome;
KW   Nucleotide-binding; Nucleus; Reference proteome; Transferase;
KW   Ubl conjugation pathway.
FT   CHAIN         1    161       Ubiquitin-conjugating enzyme E2Q-like
FT                                protein 1.
FT                                /FTId=PRO_0000335811.
FT   ACT_SITE     88     88       Glycyl thioester intermediate.
FT                                {ECO:0000269|PubMed:24000165}.
FT   MUTAGEN      88     88       C->A: Unable to bind ubiquitin.
FT                                {ECO:0000269|PubMed:24000165}.
FT   MUTAGEN      88     88       C->S: Enhanced ubiquitin binding.
FT                                {ECO:0000269|PubMed:24000165}.
SQ   SEQUENCE   161 AA;  18338 MW;  B2062702B5EFB2A2 CRC64;
     MKELQDIARL SDRFISVELV DESLFDWNVK LHQVDKDSVL WQDMKETNTE FILLNLTFPD
     NFPFSPPFMR VLSPRLENGY VLDGGAICME LLTPRGWSSA YTVEAVMRQF AASLVKGQGR
     ICRKAGKSKK SFSRKEAEAT FKSLVKTHEK YGWVTPPVSD G
//
